Related Experiment Video
Updated: May 30, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
[A new dementia group caused by TDP-43 abnormality]
Tetsuaki Arai1, Masato Hosokawa, Masato Hasegawa
1Department of Psychiatry, Graduate School of Comprehensive Human Sciences, University of Tsukuba.
Summary
The TAR DNA-binding protein (TDP-43) forms pathological aggregates in neurodegenerative diseases like ALS and FTLD-TDP. Understanding TDP-43 phosphorylation and fragmentation is key to disease pathogenesis and therapy development.
Area of Science:
- Neurodegenerative diseases
- Proteinopathies
- Molecular pathology
Context:
- TDP-43 is a key protein in ALS and FTLD-TDP, forming inclusions.
- TDP-43 pathology is also seen in Alzheimer's disease and other disorders.
- Accumulated TDP-43 exhibits phosphorylation and fragmentation.
Purpose:
- To investigate the role of TDP-43 processing in neurodegeneration.
- To understand the relationship between TDP-43 C-terminal fragments and disease subtypes.
- To explore mechanisms of TDP-43 aggregation and its pathological significance.
Summary:
- TDP-43 pathology, characterized by phosphorylation and fragmentation, is central to ALS and FTLD-TDP.
- Specific C-terminal fragments of phosphorylated TDP-43 correlate with FTLD-TDP subtypes.
- Proteolytic processing of TDP-43 appears critical in disease progression.
Impact:
- Clarifying TDP-43 pathogenesis is crucial for developing effective therapies.
- Understanding TDP-43 aggregation mechanisms may reveal new therapeutic targets.
- This research advances the understanding of TDP-43 proteinopathies.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...